Search research articles
Contact Us
Filters
Showing results (191-200 of 247) with videos related to
Page
of 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 12, 2012
Clinical benefit of response in chronic graft-versus-host disease
Yoshihiro Inamoto, Paul J Martin, Xiaoyu Chai, et al.
Annals of Internal Medicine
|
January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts
George B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report
Sophie Paczesny, Frances T Hakim, Joseph Pidala, et al.
Ophthalmology
|
December 14, 2011
Validation of measurement scales in ocular graft-versus-host disease
Yoshihiro Inamoto, Xiaoyu Chai, Brenda F Kurland, et al.
Blood
|
August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Betty L Stewart, Barry Storer, Jan Storek, et al.
Haematologica
|
August 3, 2014
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation
Brian Kornblit, David G Maloney, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 21, 2017
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease
George L Chen, Paul A Carpenter, Raewyn Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2015
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report
Stephanie J Lee, Daniel Wolff, Carrie Kitko, et al.
Blood
|
January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
Kirk R Schultz, David B Miklos, Daniel Fowler, et al.
Page
of 25
Search research articles
Search
Showing results (191-200 of 247) with videos related to
Sort By:
Page
of 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 12, 2012
Clinical benefit of response in chronic graft-versus-host disease
Yoshihiro Inamoto, Paul J Martin, Xiaoyu Chai, et al.
Annals of Internal Medicine
|
January 21, 2020
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts
George B McDonald, Brenda M Sandmaier, Marco Mielcarek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 4, 2015
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report
Sophie Paczesny, Frances T Hakim, Joseph Pidala, et al.
Ophthalmology
|
December 14, 2011
Validation of measurement scales in ocular graft-versus-host disease
Yoshihiro Inamoto, Xiaoyu Chai, Brenda F Kurland, et al.
Blood
|
August 5, 2004
Duration of immunosuppressive treatment for chronic graft-versus-host disease
Betty L Stewart, Barry Storer, Jan Storek, et al.
Haematologica
|
August 3, 2014
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation
Brian Kornblit, David G Maloney, Barry E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 21, 2017
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease
George L Chen, Paul A Carpenter, Raewyn Broady, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 23, 2015
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report
Stephanie J Lee, Daniel Wolff, Carrie Kitko, et al.
Blood
|
January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 31, 2006
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report
Kirk R Schultz, David B Miklos, Daniel Fowler, et al.
Page
of 25